Tiroid Kanserlerinde Tarama, Tanı, İzlem

Artür Salmaslıoğlu, (İstanbul Üniversitesi, İstanbul Tıp Fakültesi, Radyoloji Anabilim Dalı, İstanbul, Türkiye)
Mesut Bulakçı (Adres Yazılmamış)
Türk Radyoloji Seminerleri
4 0
Yıl: 2018 Cilt: 6 Sayı: 3 Sayfa Aralığı: 483 - 495 Metin Dili: Türkçe DOI: 10.5152/trs.2018.671 İndeks Tarihi: 20-08-2020

Tiroid Kanserlerinde Tarama, Tanı, İzlem

Öz:
-
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Diğer Erişim Türü: Erişime Açık
  • [1]. Vander JB, Gaston EA, Dawber TR. The significance of nontoxic thyroid nodules. Final report of a 15- year study of the incidence of thyroid malignancy. Ann Intern Med 1968; 69: 537-40. [CrossRef]
  • [2]. Tan, G.H. and H. Gharib, Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 1997; 126: 226-31. [CrossRef]
  • [3]. Guth S, Theune U, Aberle J, Galach A, Bamberger CM. Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination. Eur J Clin Invest 2009; 39: 699-706. [CrossRef]
  • [4]. Hegedus L. Clinical practice. The thyroid nodule. N Engl J Med 2004; 351: 1764-71. [CrossRef]
  • [5]. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006; 295: 2164-7. [CrossRef]
  • [6]. Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 2014; 140: 317-22. [CrossRef]
  • [7]. Ahn HS, Kim HJ, Welch HG. Korea's thyroid-cancer "epidemic"-screening and overdiagnosis. N Engl J Med 2014; 371: 1765-7. [CrossRef]
  • [8]. Lin JS, Bowles EJA, Williams SB, Morrison CC. Screening for Thyroid Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2017; 317: 1888- 903. [CrossRef]
  • [9]. US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, Barry MJ, Davidson KW, et al. Screening for Thyroid Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2017; 317: 1882-7. [CrossRef]
  • [10]. Galanti MR, Ekbom A, Grimelius L, Yuen J, et al. Parental cancer and risk of papillary and follicular thyroid carcinoma. Br J Cancer 1997; 75: 451-6. [CrossRef]
  • [11]. LiVolsi VA, Asa SL. The demise of follicular carcinoma of the thyroid gland. Thyroid 1994; 4: 233-6. [CrossRef]
  • [12]. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994; 97: 418- 28. [CrossRef]
  • [13]. McIver B, Hay ID, Giuffrida DF, Dvorak CE, Grant CS, Thompson GB, et al. Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery 2001; 130: 1028-34. [CrossRef]
  • [14]. Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 2015; 25: 567-610. [CrossRef]
  • [15]. Walsh S1, Lowery AJ, Evoy D, McDermott EW, Prichard RS. Thyroid lymphoma: recent advances in diagnosis and optimal management strategies. Oncologist 2013; 18: 994-1003. [CrossRef]
  • [16]. Cronan JJ. Thyroid nodules: is it time to turn off the US machines? Radiology 2008; 247: 602-4. [CrossRef]
  • [17]. Salmaslioğlu A1, Erbil Y, Dural C, Işsever H, Kapran Y, Ozarmağan S, et al. Predictive value of sonographic features in preoperative evaluation of malignant thyroid nodules in a multinodular goiter. World J Surg 2008; 32: 1948-54. [CrossRef]
  • [18]. Kim EK, Park CS, Chung WY, Oh KK, Kim DI, Lee JT, et al. New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. AJR Am J Roentgenol 2002; 178: 687-91. [CrossRef]
  • [19]. Gharib H, Papini E, Garber JR, Duick DS, Harrell RM, Hegedüs L, et al. American Association of nical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules--2016 Update. Endocr Pract 2016. 22: 622-39. [CrossRef]
  • [20]. Moon WJ1, Jung SL, Lee JH, Na DG, Baek JH, Lee YH, et al. Benign and malignant thyroid nodules: US differentiation--multicenter retrospective study. Radiology 2008; 247: 762-70. [CrossRef]
  • [21]. Malhi H1, Beland MD, Cen SY, Allgood E, Daley K, Martin SE, et al. Echogenic foci in thyroid nodules: significance of posterior acoustic artifacts. AJR Am J Roentgenol 2014; 203: 1310-6. [CrossRef]
  • [22]. Frates MC, Benson CB, Doubilet PM, Kunreuther E, Contreras M, Cibas ES, et al. Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab 2006; 91: 3411-7. [CrossRef]
  • [23]. Kwak JY, Han KH, Yoon JH, Moon HJ, Son EJ, Park SH, et al. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology 2011; 260: 892-9. [CrossRef]
  • [24]. Kim BM, Kim MJ, Kim EK, Kwak JY, Hong SW, Son EJ, et al. Sonographic differentiation of thyroid nodules with eggshell calcifications. J Ultrasound Med 2008; 27: 1425-30. [CrossRef]
  • [25]. Shin JH, Baek JH, Chung J, Ha EJ, Kim JH, Lee YH, et al. Ultrasonography Diagnosis and Imaging-Based Management of Thyroid Nodules: Revised Korean Society of Thyroid Radiology Consensus Statement and Recommendations. Korean J Radiol 2016; 17: 370-95. [CrossRef]
  • [26]. Stavros AT, Thickman D, Rapp CL, Dennis MA, Parker SH, Sisney GA. Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology 1995; 196: 123-34. [CrossRef]
  • [27]. Yoon SJ, Yoon DY, Chang SK, Seo YL, Yun EJ, Choi CS, et al. "Taller-than-wide sign" of thyroid malignancy: comparison between ultrasound and CT. AJR Am J Roentgenol 2010; 194: 420-4. [CrossRef]
  • [28]. Moon HJ1, Kwak JY, Kim EK, Kim MJ. A taller-than-wide shape in thyroid nodules in transverse and longitudinal ultrasonographic planes and the prediction of malignancy. Thyroid 2011; 21: 1249-53. [CrossRef]
  • [29]. Choi SH, Kim EK, Kwak JY, Kim MJ, Son EJ. Interobserver and intraobserver variations in ultrasound assessment of thyroid nodules. Thyroid 2010; 20: 167-72. [CrossRef]
  • [30]. Nam-Goong IS, Kim HY, Gong G, Lee HK, Hong SJ, Kim WB, et al. Ultrasonography-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findings. Clin Endocrinol (Oxf) 2004; 60: 21-8. [CrossRef]
  • [31]. Lee MJ, Kim EK, Kwak JY, Kim MJ. Partially cystic thyroid nodules on ultrasound: probability of malignancy and sonographic differentiation. Thyroid 2009; 19: 341-6. [CrossRef]
  • [32]. Li W, Zhu Q, Jiang Y, Zhang Q, Meng Z, Sun J, et al. Partially cystic thyroid nodules in ultrasound-guided fine needle aspiration: Prevalence of thyroid carcinoma and ultrasound features. Medicine (Baltimore) 2017; 96: p. e8689. [CrossRef]
  • [33]. Bonavita JA, Mayo J, Babb J, Bennett G, Oweity T, Macari M et al. Pattern recognition of benign nodules at ultrasound of the thyroid: which nodules can be left alone? AJR Am J Roentgenol 2009; 193: 207- 13. [CrossRef]
  • [34]. Frates MC1, Benson CB, Doubilet PM, Cibas ES, Marqusee E. Can color Doppler sonography aid in the prediction of malignancy of thyroid nodules? J Ultrasound Med 2003; 22: 127-31. [CrossRef]
  • [35]. Moon HJ, Kwak JY, Kim MJ, Son EJ, Kim EK. Can vascularity at power Doppler US help predict thyroid malignancy? Radiology 2010; 255: 260-9. [CrossRef]
  • [36]. Ivanac G, Brkljacic B, Ivanac K, Huzjan R, Skreb F, Cikara I. Vascularisation of benign and malignant thyroid nodules: CD US evaluation. Ultraschall Med 2007; 28: 502-6. [CrossRef]
  • [37]. Russ G. Risk stratification of thyroid nodules on ultrasonography with the French TI-RADS: description and reflections. Ultrasonography 2016; 35: 25-38. [CrossRef]
  • [38]. Zhou JQ1, Zhou C1, Zhan WW2, Zhou W1, Dong YJ. Maximal, minimal, and mean pulsed Doppler parameters: which should be utilized in the diagnosis of thyroid nodules? Clin Radiol 2014; 69: 477-84.[CrossRef]
  • [39]. Chammas MC, Gerhard R, de Oliveira IR, Widman A, de Barros N, Durazzo M, et al. Thyroid nodules: evaluation with power Doppler and duplex Doppler ultrasound. Otolaryngol Head Neck Surg 2005; 132: 874-82. [CrossRef]
  • [40]. Asteria C, Giovanardi A, Pizzocaro A, Cozzaglio L, Morabito A, Somalvico F, et al. US-elastography in the differential diagnosis of benign and malignant thyroid nodules. Thyroid 2008; 18: 523-31. [CrossRef]
  • [41]. Rago T, Santini F, Scutari M, Pinchera A, Vitti P. Elastography: new developments in ultrasound for predicting malignancy in thyroid nodules. J Clin Endocrinol Metab 2007; 92: 2917-22. [CrossRef]
  • [42]. Bojunga J, Herrmann E, Meyer G, Weber S, Zeuzem S, Friedrich-Rust M. Real-time elastography for the differentiation of benign and malignant thyroid nodules: a meta-analysis. Thyroid 2010; 20: 1145-50. [CrossRef]
  • [43]. Moon HJ, Sung JM, Kim EK, Yoon JH, Youk JH, Kwak JY. Diagnostic performance of gray-scale US and elastography in solid thyroid nodules. Radiology 2012; 262: 1002-13. [CrossRef]
  • [44]. Zhan J, Jin JM, Diao XH, Chen Y. Acoustic radiation force impulse imaging (ARFI) for differentiation of benign and malignant thyroid nodules--A meta-analysis. Eur J Radiol 2015; 84: 2181-6. [CrossRef]
  • [45]. Kim DS, Kim JH, Na DG, Park SH, Kim E, Chang KH, et al. Sonographic features of follicular variant papillary thyroid carcinomas in comparison with conventional papillary thyroid carcinomas. J Ultrasound Med 2009; 28: 1685-92. [CrossRef]
  • [46]. Frates MC, Benson CB, Charboneau JW, Cibas ES, Clark OH, Coleman BG et al. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology 2005; 237: 794-800. [CrossRef]
  • [47]. Horvath E, Majlis S, Rossi R, Franco C, Niedmann JP, Castro A, et al. An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management. J Clin Endocrinol Metab 2009; 94: 1748-51. [CrossRef]
  • [48]. Park JY, Lee HJ, Jang HW, Kim HK, Yi JH, Lee W, et al. A proposal for a thyroid imaging reporting and data system for ultrasound features of thyroid carcinoma. Thyroid 2009; 19: 1257-64. [CrossRef]
  • [49]. Russ G, Bigorgne C, Royer B, Rouxel A, Bienvenu-Perrard M. The Thyroid Imaging Reporting and Data System (TIRADS) for ultrasound of the thyroid. J Radiol 2011; 92: 701-13. [CrossRef]
  • [50]. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016; 26: 1-133. [CrossRef]
  • [51]. Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, Teefey SA, et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee. J Am Coll Radiol 2017; 14: 587-95. [CrossRef]
  • [52]. Russ G, Bonnema SJ, Erdogan MF, Durante C, Ngu R, Leenhardt L. European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADS. Eur Thyroid J 2017; 6: 225-37. [CrossRef]
  • [53]. Radiology, A. C.o., Breast imaging reporting and data system, breast imaging atlas. 5th ed. 2013, Reston, VA.
  • [54]. Ito Y, Miyauchi A, Kihara M, Higashiyama T, Kobayashi K, Miya A. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid 2014; 24: 27-34. [CrossRef]
  • [55]. Ajmal S, Rapoport S, Ramirez Batlle H, Mazzaglia PJ. The natural history of the benign thyroid nodule: what is the appropriate follow-up strategy? J Am Coll Surg 2015; 220: 987-92. [CrossRef]
  • [56]. Nakamura H, Hirokawa M, Ota H, Kihara M, Miya A, Miyauchi A. Is an Increase in Thyroid Nodule Volume a Risk Factor for Malignancy? Thyroid 2015; 25: 804-11. [CrossRef]
  • [57]. Soelberg KK, Bonnema SJ, Brix TH, Hegedüs L. Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography: a systematic review. Thyroid 2012; 22: 918-25. [CrossRef]
APA SALMASLIOĞLU A, BULAKÇI M (2018). Tiroid Kanserlerinde Tarama, Tanı, İzlem. , 483 - 495. 10.5152/trs.2018.671
Chicago SALMASLIOĞLU Artür,BULAKÇI Mesut Tiroid Kanserlerinde Tarama, Tanı, İzlem. (2018): 483 - 495. 10.5152/trs.2018.671
MLA SALMASLIOĞLU Artür,BULAKÇI Mesut Tiroid Kanserlerinde Tarama, Tanı, İzlem. , 2018, ss.483 - 495. 10.5152/trs.2018.671
AMA SALMASLIOĞLU A,BULAKÇI M Tiroid Kanserlerinde Tarama, Tanı, İzlem. . 2018; 483 - 495. 10.5152/trs.2018.671
Vancouver SALMASLIOĞLU A,BULAKÇI M Tiroid Kanserlerinde Tarama, Tanı, İzlem. . 2018; 483 - 495. 10.5152/trs.2018.671
IEEE SALMASLIOĞLU A,BULAKÇI M "Tiroid Kanserlerinde Tarama, Tanı, İzlem." , ss.483 - 495, 2018. 10.5152/trs.2018.671
ISNAD SALMASLIOĞLU, Artür - BULAKÇI, Mesut. "Tiroid Kanserlerinde Tarama, Tanı, İzlem". (2018), 483-495. https://doi.org/10.5152/trs.2018.671
APA SALMASLIOĞLU A, BULAKÇI M (2018). Tiroid Kanserlerinde Tarama, Tanı, İzlem. Türk Radyoloji Seminerleri, 6(3), 483 - 495. 10.5152/trs.2018.671
Chicago SALMASLIOĞLU Artür,BULAKÇI Mesut Tiroid Kanserlerinde Tarama, Tanı, İzlem. Türk Radyoloji Seminerleri 6, no.3 (2018): 483 - 495. 10.5152/trs.2018.671
MLA SALMASLIOĞLU Artür,BULAKÇI Mesut Tiroid Kanserlerinde Tarama, Tanı, İzlem. Türk Radyoloji Seminerleri, vol.6, no.3, 2018, ss.483 - 495. 10.5152/trs.2018.671
AMA SALMASLIOĞLU A,BULAKÇI M Tiroid Kanserlerinde Tarama, Tanı, İzlem. Türk Radyoloji Seminerleri. 2018; 6(3): 483 - 495. 10.5152/trs.2018.671
Vancouver SALMASLIOĞLU A,BULAKÇI M Tiroid Kanserlerinde Tarama, Tanı, İzlem. Türk Radyoloji Seminerleri. 2018; 6(3): 483 - 495. 10.5152/trs.2018.671
IEEE SALMASLIOĞLU A,BULAKÇI M "Tiroid Kanserlerinde Tarama, Tanı, İzlem." Türk Radyoloji Seminerleri, 6, ss.483 - 495, 2018. 10.5152/trs.2018.671
ISNAD SALMASLIOĞLU, Artür - BULAKÇI, Mesut. "Tiroid Kanserlerinde Tarama, Tanı, İzlem". Türk Radyoloji Seminerleri 6/3 (2018), 483-495. https://doi.org/10.5152/trs.2018.671
Sayfa Oluşturulma Tarihi
23-04-2024 12:57

İLETİŞİM

TÜBİTAK ULAKBİM TR Dizin

Yüzüncüyıl, İşçi Blokları Mahallesi

Muhsin Yazıcıoğlu Caddesi No:51/C

06530 Çankaya / ANKARA +90 (312) 298 92 00

trdizin@tubitak.gov.tr

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © Tüm Hakları Saklıdır. Gizlilik Politikası Kullanım Şartları